Zobrazeno 1 - 10
of 56
pro vyhledávání: '"N Ringdal"'
Autor:
N. Ringdal, P. Swinburn, R. Backman, P. Plaschke, A. P. Sips, P. Kjaersgaard, G. Bratten, T. A. J. Harris
Publikováno v:
Mediators of Inflammation, Vol 5, Iss 5, Pp 382-389 (1996)
In Vitro and in vivo data have demonstrated that there are detectable differences between inhaled corticosteroids commonly used to treat asthma. However, controversy still remains as to whether these differences translate into clinical benefits. This
Externí odkaz:
https://doaj.org/article/4fb21dc819af40eaba5432e61aa9de99
Publikováno v:
Revista Portuguesa de Pneumologia, Vol 10, Iss 2, Pp 181-183 (2004)
RESUMO: Em todo o mundo, as taxas de morbilidade e mortalidade relacionadas com a asma têm vindo a aumentar. Segundo as normas intervencionais (Guidelines), os objectivos do manejamento da asma brônquica devem ser o controlo de sintomas e a pre
Externí odkaz:
https://doaj.org/article/d6011487d8e5479887565489af90fbfc
Publikováno v:
Respiratory Medicine. 96:851-861
The aim of this study was to compare the efficacy safety and cost of Seretide (salmeterol/fluticasone propionate (Salm/FP), 50/250 microg bd) via Diskus with formoterol (Form; 12 microg bd) and budesonide (Bud; 800 microg bd) given concurrently (Form
Publikováno v:
International Journal of Clinical Practice. 55:100-106
Publikováno v:
Respiratory Medicine. 94(5):482-489
This randomized, double-blind, double-dummy, multicentre cross-over study compared the effects on the hypothalamic-pituitary-adrenal (HPA) axis of fluticasone propionate (750 microg twice daily given via the Diskus) and budesonide (800 microg twice d
Publikováno v:
Respiratory Medicine. 92(8):1040-1045
This study compared the efficacy of a low dose of formoterol Turbuhaler® 6 μg b.i.d. (F) with that of terbutaline 0·5 mg q.i.d. (T), and placebo (P) from Turbuhaler®. After a 2-week run-in, 397 adults with mild to moderate asthma were randomly al
Publikováno v:
Respiratory Medicine. 92(8):1017-1021
The aim of the study was to investigate the time of onset and the duration of the bronchodilating effect of different doses of formoterol administered via Turbuhaler in patients with moderate asthma. Thirty-one patients (five women) with a mean force
Publikováno v:
International Journal of Clinical Practice. 51:11-15
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 153:1481-1488
A study was done to compare the efficacy and safety of the coprescription of salmeterol 50 microgram twice daily or 100 microgram twice daily with beclomethasone dipropionate (BDP) 500 micrograms twice daily (SALM 50 and SALM 100) with BDP 1,000 micr
Autor:
R. Backman, P. Plaschke, P. Swinburn, P. Kjaersgaard, T. A. J. Harris, N. Ringdal, A. P. Sips, G. Bratten
Publikováno v:
Mediators of Inflammation
Mediators of Inflammation, Vol 5, Iss 5, Pp 382-389 (1996)
Mediators of Inflammation, Vol 5, Iss 5, Pp 382-389 (1996)
In Vitro and in vivo data have demonstrated that there are detectable differences between inhaled corticosteroids commonly used to treat asthma. However, controversy still remains as to whether these differences translate into clinical benefits. This